Madrigal Pharmaceuticals Inc (OQ:MDGL)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
See Regulatory Filings on SEC
Company Contact
Address: 200 Barr Harbor Dr Ste 400
Tel: N/A
IR: See website
Key People
Bill Sibold
President, Chief Executive Officer, Director
Mardi C. Dier
Chief Financial Officer, Senior Vice President
Rebecca A. Taub
President of Research and Development, Chief Medical Officer, Director
Carole Huntsman
Chief Commercial Officer
Robert Waltermire
Chief Pharmaceutical Development Officer
Business Overview
Financial Overview
For the three months ended 31 March 2024, Madrigal Pharmaceuticals Inc revenues was not reported. Net loss increased 92% to $147.5M. Higher net loss reflects General and administrative increase from $10.3M to $66.8M (expense), Research and development increase of 15% to $65.3M (expense), Stock-based Compensation in SGA increase from $5.9M to $14M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$4.23 to -$7.38.
Employees: 376 as of Feb 22, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $4,939M as of Mar 31, 2024
Annual revenue (TTM): $0.00M as of Mar 31, 2024
EBITDA (TTM): -$453.63M as of Mar 31, 2024
Net annual income (TTM): -$444.28M as of Mar 31, 2024
Free cash flow (TTM): -$391.12M as of Mar 31, 2024
Net Debt Last Fiscal Year: N/A
Shares outstanding: 21,311,526 as of May 3, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.